Antibe Therapeutics (ATBPD) Stock Chart & Stock Price History → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free ATBPD Stock Alerts $0.22 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisChartStock AnalysisChart Antibe Therapeutics Stock Price Performance5 Day PerformanceN/A1 Month PerformanceN/A3 Month Performance-69.14%6 Month Performance-58.87%Year-To-Date Performance-68.33%1 Year Performance-43.12% Receive ATBPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. ATBPD Stock Chart for Saturday, May, 18, 2024 ATBPD Chart by TradingView Antibe Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/09/2024$0.21$0.19-8.92%$0.25$0.1922,355 shs$73.53 million04/08/2024$0.21$0.21$0.23$0.19115,129 shs$80.73 million04/05/2024$0.19$0.21+7.73%$0.23$0.2079,629 shs$80.88 million04/04/2024$0.12$0.19+68.26%$0.22$0.15151,112 shs$75.08 million04/03/2024$0.12$0.12+0.26%$0.14$0.11181,162 shs$44.62 million04/02/2024$0.33$0.12-65.62%$0.17$0.11181,162 shs$44.51 million Get the Latest News and Ratings for ATBPD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/01/2024$0.33$0.33$0.33$0.33940 shs$129.45 million03/29/2024$0.32$0.33+5.11%$0.33$0.33940 shs$129.45 million03/28/2024$0.32$0.32-1.56%$0.32$0.32750 shs$123.16 million03/27/2024$0.31$0.32+4.29%$0.32$0.3211,075 shs$125.12 million03/25/2024$0.31$0.31$0.33$0.3152,076 shs$119.97 million03/22/2024$0.31$0.31+2.91%$0.31$0.3121,936 shs$121.75 million03/21/2024$0.31$0.31-0.31%$0.31$0.3145,159 shs$118.31 million03/20/2024$0.32$0.31-4.29%$0.33$0.3049,842 shs$118.67 million03/19/2024$0.32$0.32-1.39%$0.32$0.321,565 shs$124.00 million03/18/2024$0.32$0.32$0.33$0.32964 shs$125.74 million03/15/2024$0.34$0.33-2.51%$0.35$0.3344,970 shs$129.26 million03/14/2024$0.34$0.34-0.12%$0.36$0.3310,500 shs$132.59 million03/13/2024$0.32$0.34+7.19%$0.34$0.3410,500 shs$132.74 million03/12/2024$0.34$0.32-5.02%$0.36$0.3112,800 shs$123.84 million03/11/2024$0.34$0.34$0.37$0.347,140 shs$130.38 million03/08/2024$0.39$0.39+0.49%$0.41$0.3968,710 shs$150.93 million03/07/2024$0.40$0.39-2.00%$0.43$0.3279,253 shs$150.20 million03/06/2024$0.39$0.40+1.59%$0.40$0.3845,325 shs$153.27 million03/05/2024$0.73$0.39-46.67%$0.43$0.24190,476 shs$150.88 million03/04/2024$0.73$0.73$0.73$0.729,150 shs$282.90 million03/01/2024$0.72$0.71-0.50%$0.72$0.714,410 shs$276.55 million02/29/2024$0.74$0.72-2.29%$0.74$0.7121,284 shs$277.94 million02/28/2024$0.77$0.74-4.92%$0.77$0.7434,043 shs$284.45 million02/27/2024$0.78$0.77-0.82%$0.78$0.7715,838 shs$299.15 million02/26/2024$0.78$0.78$0.79$0.73160,985 shs$301.63 million02/23/2024$0.72$0.72+0.49%$0.73$0.7213,041 shs$278.06 million02/22/2024$0.72$0.72-0.42%$0.73$0.719,516 shs$276.71 million02/21/2024$0.70$0.72+2.57%$0.73$0.7040,389 shs$277.87 million02/20/2024$0.70$0.70$0.70$0.683,799 shs$270.90 million02/19/2024$0.70$0.70$0.70$0.683,799 shs$270.90 million Related Companies: LifeVantage Stock Price Chart Sernova Stock Price Chart Q32 Bio Stock Price Chart Aclaris Therapeutics Stock Price Chart Chimerix Stock Price Chart Connect Biopharma Stock Price Chart Provectus Biopharmaceuticals Stock Price Chart Vaccitech Stock Price Chart Affimed Stock Price Chart Hookipa Pharma Stock Price Chart Receive ATBPD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ATBPD) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaObama’s Forever Term [exposed]Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryMost important medical advance in 100 yearsThe Oxford ClubBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Antibe Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
